Tell me why we should reauthorize user fees for pharmaceuticals and devices when, in the case of devices, the length of time has gone up since we instituted user fees?
On the recordJuly 27, 2011
Source
congress.govEditor's note · Context
Questioning the need for reauthorizing user fees due to increased approval times.
Share
More from Richard Burr
Apr 4, 2022
I question whether the agreements both passed and proposed reflect a good deal for patients they are designed to serve.
Apr 25, 2022
I as an applicant should feel good about that. That tells me that there are less people working on application.
Jun 15, 2022
I will continue to ask you for a plan until we get one, and I will continue to be a roadblock for those who believe that we can blindly just appropriate emergency money.
Sep 14, 2022
I thank my colleague from Mississippi. There are going to be some who say this is unprecedented by the Congress. In fact, under the Railway Labor Act, Congress is allowed to intervene. In fact, Congress has intervened 18 times in the past…





